A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

ORMP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Oramed Pharmaceuticals Insider Trading History Chart

Oramed Pharmaceuticals Share Price & Price History

^$2.27

▲ +0.07 (3.18%)

As of 04/19/2024 01:00 AM ET

Days: 30 | 90 | 365

Secret Bull Market Starts in This Unusual Sector

From Altimetry | Ad

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

Oramed Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/16/2023	Nadav Kidron	CEO	Buy	26,000	$2.04	$53,040.00	126,000
3/14/2023	Nadav Kidron	CEO	Buy	100,000	$2.01	$201,000.00	100,000
3/13/2023	Yadin Rozov	Director	Buy	20,000	$1.96	$39,200.00	36,500
1/3/2023	Michael Rabinowitz	Insider	Sell	13,325	$12.55	$167,228.75	126,143
3/21/2022	Kevin Rakin	Director	Sell	10,000	$9.41	$94,100.00
9/16/2021	Kevin Rakin	Director	Sell	21,100	$20.99	$442,889.00
8/9/2021	Nadav Kidron	CEO	Sell	220,000	$20.11	$4,424,200.00	648,573

Secret Bull Market Starts in This Unusual Sector

From Altimetry | Ad

Click for my No. 1 investment, all free of charge, click here.

SEC Filings (Institutional Ownership Changes) for Oramed Pharmaceuticals (NASDAQ:ORMP)

12.73% of Oramed Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Oramed Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/15/2024	Barclays PLC	13,239	$30K	0.0%	-28.1%	0.033%
2/15/2024	Murchinson Ltd.	1,050,000	$2.43M	0.4%	N/A	2.603%
1/30/2024	BML Capital Management LLC	1,261,559	$2.91M	2.2%	+61.5%	3.127%
11/30/2023	American Century Companies Inc.	18,764	$49K	0.0%	+59.2%	0.047%
11/15/2023	GSA Capital Partners LLP	88,923	$0.23M	0.0%	-46.0%	0.220%
11/14/2023	Qube Research & Technologies Ltd	9,890	$26K	0.0%	N/A	0.025%
11/13/2023	Algert Global LLC	14,680	$38K	0.0%	N/A	0.036%
11/13/2023	LPL Financial LLC	37,216	$97K	0.0%	+129.5%	0.092%
11/13/2023	Rathbones Group PLC	289,803	$0.76M	0.0%	N/A	0.718%
11/13/2023	Invesco Ltd.	10,094	$26K	0.0%	N/A	0.025%
11/7/2023	Barclays PLC	18,406	$47K	0.0%	+39.0%	0.046%
11/6/2023	N.E.W. Advisory Services LLC	12,960	$34K	0.0%	N/A	0.032%
10/23/2023	BML Capital Management LLC	781,292	$2.04M	1.9%	-8.1%	1.940%
9/21/2023	Barclays PLC	13,239	$47K	0.0%	-35.9%	0.033%
8/15/2023	Goldman Sachs Group Inc.	90,915	$0.33M	0.0%	-9.9%	0.226%
8/14/2023	Tower Research Capital LLC TRC	9,344	$33K	0.0%	+27,382.4%	0.023%
8/14/2023	Schonfeld Strategic Advisors LLC	30,300	$0.11M	0.0%	+74.1%	0.075%
8/11/2023	Renaissance Technologies LLC	33,700	$0.12M	0.0%	+183.2%	0.084%
8/11/2023	BlackRock Inc.	98,030	$0.35M	0.0%	+9.3%	0.245%
8/11/2023	JPMorgan Chase & Co.	53,851	$0.19M	0.0%	-69.1%	0.135%
8/10/2023	Citigroup Inc.	37,444	$0.13M	0.0%	+49.4%	0.094%
8/7/2023	Acadian Asset Management LLC	31,736	$0.11M	0.0%	N/A	0.079%
8/3/2023	Barclays PLC	13,239	$47K	0.0%	-35.9%	0.033%
7/31/2023	LPL Financial LLC	16,216	$58K	0.0%	N/A	0.041%
7/26/2023	Glass Jacobson Investment Advisors llc	12,255	$44K	0.0%	N/A	0.031%
7/24/2023	BML Capital Management LLC	850,000	$3.04M	2.7%	-37.3%	2.123%
5/18/2023	JPMorgan Chase & Co.	174,122	$0.38M	0.0%	-57.0%	0.435%
5/16/2023	Susquehanna International Group Ltd.	113,526	$0.25M	0.1%	N/A	0.284%
5/16/2023	Susquehanna International Group LLP	14,189	$31K	0.0%	-90.2%	0.035%
5/16/2023	Apollon Wealth Management LLC	20,000	$44K	0.0%	N/A	0.050%
5/16/2023	Jane Street Group LLC	40,905	$89K	0.0%	-60.3%	0.102%
5/16/2023	State Street Corp	53,866	$0.12M	0.0%	+5.6%	0.135%
5/15/2023	Schonfeld Strategic Advisors LLC	17,400	$38K	0.0%	N/A	0.043%
5/15/2023	Two Sigma Securities LLC	12,962	$28K	0.0%	N/A	0.032%
5/15/2023	Two Sigma Advisers LP	444,900	$0.97M	0.0%	+76.6%	1.111%
5/15/2023	Two Sigma Investments LP	506,255	$1.10M	0.0%	N/A	1.265%
5/15/2023	XTX Topco Ltd	151,620	$0.33M	0.1%	+165.6%	0.381%
5/12/2023	Renaissance Technologies LLC	11,900	$26K	0.0%	N/A	0.030%
5/12/2023	Corsair Capital Management L.P.	47,256	$0.10M	0.0%	N/A	0.119%
5/12/2023	BlackRock Inc.	89,671	$0.20M	0.0%	-15.3%	0.225%
5/12/2023	Bank of America Corp DE	57,286	$0.13M	0.0%	+203.8%	0.144%
5/12/2023	HRT Financial LP	45,035	$98K	0.0%	N/A	0.113%
5/12/2023	UBS Group AG	99,134	$0.22M	0.0%	+825.4%	0.249%
5/11/2023	Cambridge Investment Research Advisors Inc.	18,372	$40K	0.0%	+50.8%	0.046%
5/11/2023	Citigroup Inc.	25,056	$55K	0.0%	-62.0%	0.063%
5/4/2023	Barclays PLC	20,649	$45K	0.0%	-48.1%	0.052%
4/18/2023	ETF Managers Group LLC	68,940	$0.15M	0.0%	N/A	0.173%
4/14/2023	BML Capital Management LLC	1,355,925	$2.96M	2.6%	N/A	3.409%
2/16/2023	Altshuler Shaham Ltd	12,847	$0.15M	0.0%	N/A	0.033%
2/15/2023	Millennium Management LLC	490,203	$5.90M	0.0%	-2.6%	1.253%
2/15/2023	Morgan Stanley	316,391	$3.81M	0.0%	-40.0%	0.809%
2/15/2023	Man Group plc	55,316	$0.67M	0.0%	-22.1%	0.141%
2/14/2023	683 Capital Management LLC	20,537	$0.25M	0.0%	N/A	0.052%
2/14/2023	Marshall Wace LLP	37,399	$0.45M	0.0%	+31.6%	0.096%
2/13/2023	Wells Fargo & Company MN	64,682	$0.78M	0.0%	+9.0%	0.165%
2/13/2023	Barclays PLC	39,778	$0.48M	0.0%	+84.6%	0.102%
2/13/2023	GSA Capital Partners LLP	46,039	$0.55M	0.1%	N/A	0.118%
2/13/2023	JPMorgan Chase & Co.	404,617	$4.87M	0.0%	+42.2%	1.034%
2/10/2023	Bank of America Corp DE	18,857	$0.23M	0.0%	-24.8%	0.048%
2/9/2023	Landscape Capital Management L.L.C.	26,220	$0.32M	0.0%	N/A	0.067%
2/9/2023	Citigroup Inc.	65,890	$0.79M	0.0%	+115.0%	0.168%
2/8/2023	Belpointe Asset Management LLC	29,900	$0.36M	0.0%	N/A	0.076%
2/8/2023	Russell Investments Group Ltd.	56,516	$0.68M	0.0%	N/A	0.144%
2/6/2023	Glass Jacobson Investment Advisors llc	9,350	$0.11M	0.1%	N/A	0.024%
2/1/2023	Private Portfolio Partners LLC	53,600	$0.65M	0.2%	-20.5%	0.137%
2/1/2023	Janney Montgomery Scott LLC	12,379	$0.15M	0.0%	N/A	0.032%
1/26/2023	Calamos Advisors LLC	14,746	$0.18M	0.0%	N/A	0.038%
1/25/2023	Lindbrook Capital LLC	383,351	$4.61M	0.6%	N/A	0.980%
1/18/2023	Private Advisor Group LLC	11,794	$0.14M	0.0%	N/A	0.030%
11/15/2022	Two Sigma Advisers LP	331,500	$2.15M	0.0%	-51.4%	0.848%
11/15/2022	Two Sigma Investments LP	163,015	$1.06M	0.0%	-74.5%	0.417%
11/15/2022	Marshall Wace LLP	28,409	$0.19M	0.0%	+45.6%	0.073%
11/15/2022	ETF Managers Group LLC	94,493	$0.61M	0.0%	+8.2%	0.242%
11/15/2022	BlackRock Inc.	102,199	$0.66M	0.0%	-26.5%	0.261%
11/14/2022	Cubist Systematic Strategies LLC	117,477	$0.76M	0.0%	+66.1%	0.303%
11/14/2022	Ergoteles LLC	24,149	$0.16M	0.0%	-89.3%	0.062%
11/10/2022	UBS Group AG	8,415	$54K	0.0%	+84.9%	0.022%
11/10/2022	Phoenix Holdings Ltd.	13,634	$89K	0.0%	-73.2%	0.035%
11/7/2022	Virtu Financial LLC	21,526	$0.14M	0.0%	-19.3%	0.055%
11/7/2022	Private Portfolio Partners LLC	67,400	$0.44M	0.1%	+24.8%	0.174%
11/3/2022	Barclays PLC	21,543	$0.14M	0.0%	+8.7%	0.055%
10/31/2022	SG Americas Securities LLC	10,370	$67K	0.0%	-77.7%	0.027%
10/21/2022	Morgan Jess S & Co. Inc.	366,401	$2.37M	2.1%	+16.2%	0.944%
10/17/2022	Cambridge Investment Research Advisors Inc.	14,184	$92K	0.0%	+26.8%	0.037%
8/18/2022	Goldman Sachs Group Inc.	28,363	$0.13M	0.0%	-59.6%	0.073%
8/15/2022	Occudo Quantitative Strategies LP	100,216	$0.46M	0.0%	+84.8%	0.260%
8/15/2022	State Street Corp	46,009	$0.21M	0.0%	-91.4%	0.119%
8/15/2022	Cubist Systematic Strategies LLC	70,721	$0.32M	0.0%	-70.8%	0.183%
8/15/2022	Laurion Capital Management LP	12,393	$57K	0.0%	N/A	0.032%
8/15/2022	Millennium Management LLC	580,383	$2.66M	0.0%	+59.6%	1.505%
8/13/2022	Virtu Financial LLC	26,661	$0.12M	0.0%	N/A	0.069%
8/13/2022	Renaissance Technologies LLC	359,697	$1.65M	0.0%	N/A	0.933%
8/12/2022	Northern Trust Corp	13,640	$62K	0.0%	-95.2%	0.035%
8/12/2022	FMR LLC	83,857	$0.38M	0.0%	+73.4%	0.217%
8/12/2022	BNP Paribas Arbitrage SA	68,350	$0.31M	0.0%	-8.9%	0.177%
8/11/2022	Bank of Montreal Can	249,200	$1.35M	0.0%	N/A	0.646%
8/11/2022	JPMorgan Chase & Co.	336,549	$1.54M	0.0%	+1,796.3%	0.873%
8/8/2022	Oppenheimer & Co. Inc.	50,000	$0.23M	0.0%	+5.4%	0.130%
8/2/2022	Private Portfolio Partners LLC	54,010	$0.25M	0.1%	+27.8%	0.140%
7/29/2022	SG Americas Securities LLC	46,532	$0.21M	0.0%	N/A	0.121%

Data available starting January 2016

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules for delivery of polypeptides. The company's product portfolio includes ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes, as well as in phase II clinical trial for the treatment of non-alcoholic steatohepatitis; and ORA-D-013-1 and ORA-D-013-2, which have completed phase II clinical trial for the treatment of type 2 diabetes. It has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York.

Today's Range

Now: $2.27

$2.18

$2.30

50 Day Range

MA: $2.91

$2.20

$3.58

52 Week Range

Now: $2.27

$1.67

$5.25

Volume

113,647 shs

Average Volume

171,347 shs

Market Capitalization

$91.98 million

P/E Ratio

16.21

Dividend Yield

N/A

Beta

1.81

Who are the company insiders with the largest holdings of Oramed Pharmaceuticals?: Oramed Pharmaceuticals' top insider investors include:
Michael Rabinowitz (Insider)
Nadav Kidron (CEO)
Yadin Rozov (Director)
Learn More about top insider investors at Oramed Pharmaceuticals.

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad